Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

HIV Infection

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 25 articles: HTML format

Single Articles

November 2025
1. NEWTON R, Tenet V, Mugisha J, Kimono B, et al
   Human papillomavirus infection and vaccination among young females in rural Uganda.
   Int J Cancer. 2025 Nov 6. doi: 10.1002/ijc.70227.
   PubMed     Abstract available
   
   
   October 2025
2. ZHENG Y, Han J, Qu Y, Wang J, et al
   Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian population.
   Int J Cancer. 2025 Oct 23. doi: 10.1002/ijc.70204.
   PubMed     Abstract available
   
   
   
3. CHINULA L, Chagomerana MB, Mkochi T, Msowoya L, et al
   Single visit screen-triage-treat strategy using GeneXpert-based HPV testing of self-collected cervicovaginal samples and thermal ablation treatment for cervical cancer prevention among women in Lilongwe, Malawi.
   Int J Cancer. 2025 Oct 16. doi: 10.1002/ijc.70177.
   PubMed     Abstract available
   
   
   
4. YU X, Nzoutchoum OL, Gao D, Hsu CD, et al
   Cervical cancer screening and prevalence among older US Medicare beneficiaries with and without HIV.
   Int J Cancer. 2025 Oct 13. doi: 10.1002/ijc.70193.
   PubMed     Abstract available
   
   
   September 2025
5. LIU H, Zou Z, Zhang L
   Reply to 'Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis"'.
   Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70129.
   PubMed    
   
   
   
6. LIU Z, Tong X
   Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis".
   Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70130.
   PubMed    
   
   
   
7. SAEEDI E, Nemati S, Lotfi F, Domingues A, et al
   IRANCANSURV: A comprehensive analysis of childhood cancer survival in Iran.
   Int J Cancer. 2025 Sep 1. doi: 10.1002/ijc.70100.
   PubMed     Abstract available
   
   
   August 2025
8. ZHAO J, Zhang Y, Li K, Xu L, et al
   Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study.
   Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70115.
   PubMed     Abstract available
   
   
   
9. FENG X, Patel EU, Kigozi G, Gravitt PE, et al
   Longitudinal patterns of penile human papillomavirus detection among Ugandan men: A prospective sampling study.
   Int J Cancer. 2025 Aug 25. doi: 10.1002/ijc.70107.
   PubMed     Abstract available
   
   
   
10. HAAS CB, Ocampo R, Liu D, Zuniga M, et al
    Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70082.
    PubMed     Abstract available
    
    
    
11. LOPES-ARAUJO HF, Guimaraes RL, Carvalho-Silva WHV
    Correlations between new HIV infections and hospital admissions for non-Hodgkin lymphoma in Brazil.
    Int J Cancer. 2025 Aug 6. doi: 10.1002/ijc.70076.
    PubMed     Abstract available
    
    
    
12. ROZEMEIJER K, Dias Goncalves Lima F, Kuyvenhoven EJ, de Vries HJC, et al
    Swab-based anal cancer screening in men living with HIV: Projected outcomes for different screening algorithms.
    Int J Cancer. 2025 Aug 5. doi: 10.1002/ijc.70046.
    PubMed     Abstract available
    
    
    July 2025
13. BELLO-PEREZ M, Mascarell P, Fernandez-Gonzalez M, Garcia JA, et al
    ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology.
    Int J Cancer. 2025 Jul 24. doi: 10.1002/ijc.70050.
    PubMed     Abstract available
    
    
    June 2025
14. ZHENG Y, Han J, Qu Y, Wang J, et al
    DNA methylation biomarkers for cervical cancer risk prediction in HIV-positive Nigerian women.
    Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35502.
    PubMed     Abstract available
    
    
    
15. JENKINS M, Saidu R, Boa R, Mbatani N, et al
    Performance of thermoablation among women treated for high-risk human papillomavirus in a screen-and-treat program in South Africa.
    Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35519.
    PubMed     Abstract available
    
    
    May 2025
16. PISELLI P, Tavelli A, Cimaglia C, Muccini C, et al
    Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data.
    Int J Cancer. 2025 May 29. doi: 10.1002/ijc.35493.
    PubMed     Abstract available
    
    
    February 2025
17. KEBEDE HB, Mekuria S, Asegid N, Forslund O, et al
    High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia: A community-based cohort study.
    Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335.
    PubMed     Abstract available
    
    
    January 2025
18. NALWOGA A, Jackson C, Fiorillo S, Manyeruke F, et al
    Evaluation of plasma alpha-1-antichymotrypsin as a marker for pulmonary Kaposi sarcoma.
    Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35351.
    PubMed     Abstract available
    
    
    December 2024
19. MOTLHALE M, Sitas F, de Villiers CB, Simba H, et al
    Smokeless tobacco (snuff) and site-specific cancer risks in adult Black South African women: Findings from the Johannesburg Cancer Study.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35293.
    PubMed     Abstract available
    
    
    November 2024
20. LIU H, Zou M, Shen M, Kamarulzaman A, et al
    HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis.
    Int J Cancer. 2024 Nov 17. doi: 10.1002/ijc.35242.
    PubMed     Abstract available
    
    
    September 2024
21. DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al
    Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study.
    Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35190.
    PubMed     Abstract available
    
    
    August 2024
22. DUSINGIZE JC, Murenzi G, Muhoza B, Businge L, et al
    Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda from 2007 to 2018.
    Int J Cancer. 2024 Aug 11. doi: 10.1002/ijc.35091.
    PubMed     Abstract available
    
    
    April 2024
23. VASAVADA A, Stankiewicz Karita HC, Lin J, Schouten J, et al
    Methylation markers for anal cancer screening: A repeated cross-sectional analysis of people living with HIV, 2015-2016.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34977.
    PubMed     Abstract available
    
    
    
24. DOWNHAM L, Rol ML, Forestier M, Romero P, et al
    Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
    Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953.
    PubMed     Abstract available
    
    
    
25. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.